Catherine Novack
Stock Analyst at Jones Trading
(0.18)
# 4,071
Out of 4,818 analysts
18
Total ratings
13.33%
Success rate
-27.22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLYB Rallybio | Downgrades: Hold | n/a | $0.30 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $27.00 | +66.67% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $1.46 | +656.01% | 1 | Feb 12, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $130 | $18.12 | +617.44% | 1 | Nov 18, 2024 | |
| CAPR Capricor Therapeutics | Initiates: Buy | $40 | $13.18 | +203.49% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $0.48 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $6.81 | +134.95% | 2 | Sep 25, 2024 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $14 | $2.27 | +518.10% | 1 | Sep 12, 2024 | |
| DARE Daré Bioscience | Maintains: Buy | $5 → $13 | $3.01 | +331.89% | 2 | Aug 16, 2024 | |
| RGLS Regulus Therapeutics | Initiates: Buy | $8 | $2.55 | +213.73% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.97 | +151.89% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.24 | +706.45% | 1 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $1.52 | +1,347.37% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.58 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $2.78 | +5,655.40% | 1 | Jul 21, 2023 |
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.30
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $27.00
Upside: +66.67%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $1.46
Upside: +656.01%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $18.12
Upside: +617.44%
Capricor Therapeutics
Nov 18, 2024
Initiates: Buy
Price Target: $40
Current: $13.18
Upside: +203.49%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.48
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $6.81
Upside: +134.95%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $2.27
Upside: +518.10%
Daré Bioscience
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $3.01
Upside: +331.89%
Regulus Therapeutics
May 31, 2024
Initiates: Buy
Price Target: $8
Current: $2.55
Upside: +213.73%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $3.97
Upside: +151.89%
Mar 20, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.24
Upside: +706.45%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $1.52
Upside: +1,347.37%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.58
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $2.78
Upside: +5,655.40%